These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27838604)

  • 21. Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease.
    Martinez Cantarin MP; Keith SW; Waldman SA; Falkner B
    Nephrol Dial Transplant; 2014 Dec; 29(12):2268-77. PubMed ID: 25049200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of kidney failure and hemodialysis on protein and amino acid metabolism.
    Garibotto G; Bonanni A; Verzola D
    Curr Opin Clin Nutr Metab Care; 2012 Jan; 15(1):78-84. PubMed ID: 22108097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
    Nomura-Nakayama K; Adachi H; Miyatake N; Hayashi N; Fujimoto K; Yamaya H; Yokoyama H
    PLoS One; 2018; 13(5):e0195066. PubMed ID: 29718962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.
    Zoccali C; Postorino M; Marino C; Pizzini P; Cutrupi S; Tripepi G;
    J Intern Med; 2011 Feb; 269(2):172-81. PubMed ID: 21138492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation in end-stage renal disease--what have we learned in 10 years?
    Carrero JJ; Stenvinkel P
    Semin Dial; 2010; 23(5):498-509. PubMed ID: 21039875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
    Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
    Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
    Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
    Kalantar-Zadeh K; Mehrotra R; Fouque D; Kopple JD
    Semin Dial; 2004; 17(6):455-65. PubMed ID: 15660576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin as a Target in Obesity-related Inflammatory State.
    Ohashi K; Yuasa D; Shibata R; Murohara T; Ouchi N
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):145-50. PubMed ID: 25772181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.
    Wang Y; Ma XL; Lau WB
    Trends Endocrinol Metab; 2017 Jul; 28(7):519-530. PubMed ID: 28473178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malnutrition and wasting in renal disease.
    Muscaritoli M; Molfino A; Bollea MR; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):378-83. PubMed ID: 19474712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
    Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
    Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adipose tissue production of adiponectin is increased in end-stage renal disease.
    Martinez Cantarin MP; Waldman SA; Doria C; Frank AM; Maley WR; Ramirez CB; Keith SW; Falkner B
    Kidney Int; 2013 Mar; 83(3):487-94. PubMed ID: 23283133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
    Caglar K; Hakim RM; Ikizler TA
    Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders.
    Francischetti EA; Dezonne RS; Pereira CM; de Moraes Martins CJ; Celoria BMJ; de Oliveira PAC; de Abreu VG
    Horm Metab Res; 2020 Oct; 52(10):695-707. PubMed ID: 32927496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor.
    Clark JL; Taylor CG; Zahradka P
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):200-206. PubMed ID: 28820074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin, an unlocking adipocytokine.
    Sun Y; Xun K; Wang C; Zhao H; Bi H; Chen X; Wang Y
    Cardiovasc Ther; 2009; 27(1):59-75. PubMed ID: 19207481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study.
    Tung CW; Hsu YC; Shih YH; Lin CL
    PLoS One; 2015; 10(10):e0141058. PubMed ID: 26474473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.